Comparison of nanogel drug carriers and their formulations with nucleoside 5'-triphosphates.
about
Combination of nanogel polyethylene glycol-polyethylenimine and 6(hydroxymethyl)-1,4-anthracenedione as an anticancer nanomedicineNanogels as pharmaceutical carriers: finite networks of infinite capabilitiesEfficient overcoming of drug resistance to anticancer nucleoside analogs by nanodelivery of active phosphorylated drugsBiodegradable nanogels for oral delivery of interferon for norovirus infectionDegradable gene delivery systems based on Pluronics-modified low-molecular-weight polyethylenimine: preparation, characterization, intracellular trafficking, and cellular distributionFormulations of biodegradable Nanogel carriers with 5'-triphosphates of nucleoside analogs that display a reduced cytotoxicity and enhanced drug activityCurcumin-encapsulating Nanogels as an Effective Anticancer Formulation for Intracellular Uptake.Polymeric nanogel formulations of nucleoside analogs.Polymeric nanogels containing the triphosphate form of cytotoxic nucleoside analogues show antitumor activity against breast and colorectal cancer cell lines.Chemical engineering of nanogel drug carriers: increased bioavailability and decreased cytotoxicity.FOLATE-TARGETED POLYFORMULATIONS OF CYTOTOXIC NUCLEOSIDE TRIPHOSPHATES AND PACLITAXEL.Application of nanogel systems in the administration of local anesthetics.Basic concepts and recent advances in nanogels as carriers for medical applications.Multicompartmental particles for combined imaging and siRNA delivery.Lipophilic prodrugs of nucleoside triphosphates as biochemical probes and potential antiviralsCatalytic dephosphorylation of adenosine monophosphate (AMP) to form supramolecular nanofibers/hydrogels.PH responsive polypeptide based polymeric micelles for anticancer drug delivery.Characteristics of complexes between poly(propylene imine) dendrimers and nucleotides
P2860
Q24642889-019EA8A4-0537-4442-AA22-4B2CD33FB492Q33859898-2E71EE48-813A-498B-A5B9-B945D749CC25Q33997393-4004F09C-F18F-4A78-A9FE-A1BFB06F883DQ34525191-27F4270F-2901-427F-8401-A76E8B4FEE51Q35797568-8A98F83F-5C44-4352-A926-0B0C5E0E27D6Q36023585-BE46DEAC-04B5-436C-8FF3-443D54715B56Q36629010-B571889F-1018-41A1-AB37-CEC24029AFC8Q36668023-1E83DB0E-6447-41EA-92DF-3B6E072C0C30Q36994110-94533BEF-CCA2-4A46-825B-4513E6601C06Q37012594-4897C5BA-D6F8-4FBF-BEC2-48F7803223DAQ37012646-9147B988-6202-4F42-A313-768710A03D10Q38037055-EFAF5CB5-7C57-4E85-8405-70CB35697A96Q38970116-D041AE81-DE4A-4E3F-A2A0-682B62BE9F57Q39348901-10B1ED94-5219-4221-AD40-B56584C7F14EQ40936332-140A6329-9D11-4252-91AE-1E0A1211B0A9Q42411611-C0838D9E-B24C-4DA5-BF89-D363C2C1351AQ42830310-6CF3C22A-149E-48B4-B696-F39F97698977Q57777281-D2AE9586-BB74-422A-8974-9DBE384CDB5F
P2860
Comparison of nanogel drug carriers and their formulations with nucleoside 5'-triphosphates.
description
2006 nî lūn-bûn
@nan
2006 թուականի Մայիսին հրատարակուած գիտական յօդուած
@hyw
2006 թվականի մայիսին հրատարակված գիտական հոդված
@hy
2006年の論文
@ja
2006年論文
@yue
2006年論文
@zh-hant
2006年論文
@zh-hk
2006年論文
@zh-mo
2006年論文
@zh-tw
2006年论文
@wuu
name
Comparison of nanogel drug car ...... h nucleoside 5'-triphosphates.
@ast
Comparison of nanogel drug car ...... h nucleoside 5'-triphosphates.
@en
type
label
Comparison of nanogel drug car ...... h nucleoside 5'-triphosphates.
@ast
Comparison of nanogel drug car ...... h nucleoside 5'-triphosphates.
@en
prefLabel
Comparison of nanogel drug car ...... h nucleoside 5'-triphosphates.
@ast
Comparison of nanogel drug car ...... h nucleoside 5'-triphosphates.
@en
P2093
P2860
P1476
Comparison of nanogel drug car ...... h nucleoside 5'-triphosphates.
@en
P2093
Arin D Zeman
Ekta Kohli
Serguei V Vinogradov
P2860
P304
P356
10.1007/S11095-006-9788-5
P577
2006-05-02T00:00:00Z